AdaptHealth Corp. (AHCO): insider & executive buying
AdaptHealth Corp. · Health Care · ref. ETF XLV · price $6.33
In short — 2 insiders bought AdaptHealth Corp. over ~6 months (3 buys, total $521k, latest Aug 6, 26) — cluster buy. Public Form 4 data, informative (not a performance signal).
Are AdaptHealth Corp.'s executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$6.33-30.0% over range
Oct 14, 25low $5.22 · high $13.38Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 6 analysts
Latest insider buys on AdaptHealth Corp.
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Aug 6, 26 | Wolf Dale B | Dir | 20,000 | $126k |
| Aug 6, 26 | Samet Kenneth A | Dir | 23,500 | $150k |
| Aug 6, 26 | Wolf Dale B | Dir | 40,000 | $245k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have AdaptHealth Corp.'s executives bought shares recently?
2 AdaptHealth Corp. insider(s) bought $521k over ~6 months (latest Aug 6, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for AHCO?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about AdaptHealth Corp.? The JPI assistant answers using our backtest data.
Keep exploring AdaptHealth Corp.